March 15, 2024 —  Following the recent CE approval of the Solia S lead1 for LBBAP, BIOTRONIK proudly announces the world’s first and only complete CSP system, now fully CE-approved for Left Bundle Branch Area Pacing (LBBAP).2  

March 15, 2024 —  BioCardia, Inc. , a biotechnology company focused on advancing late-stage

March 15, 2024 —  Following the recent CE approval of the Solia S lead1 for LBBAP, Biotronik announces the world’s first and only complete CSP system, now fully CE-approved for Left Bundle Branch Area Pacing (LBBAP).2  

March 15, 2024 —  BioCardia, Inc., a biotechnology company focused on advancing late-stage

March 21, 2024 — The UCLA Department of Medicine has announced that Priscilla Hsue, MD will be joining as the chief of the UCLA Division of Cardiology at UCLA, effective July 1, 2024.

March 14, 2024 — The American Medical Association (AMA) has issued a new letter to federal officials in which it praised the creation of the Change Healthcare/Optum Payment Disruption (CHOPD) Accelerated Payments as “helpful for physician p

March 13, 2024 — In the largest randomized clinical trial and first of its kind to date in the United States, a team led by investigators at Beth Israel Deaconess Medical Center (BIDMC) assessed the efficacy and safety of using a drug-coated balloon in patients undergoing coronary angioplasty.

Subscribe Now